TU Darmstadt / ULB / TUprints

MeCP2 heterochromatin organization is modulated by arginine methylation and serine phosphorylation

Schmidt, Annika ; Frei, Jana ; Poetsch, Ansgar ; Chittka, Alexandra ; Zhang, Hui ; Aßmann, Chris ; Lehmkuhl, Anne ; Bauer, Uta-Maria ; Nuber, Ulrike A. ; Cardoso, M. Cristina (2022)
MeCP2 heterochromatin organization is modulated by arginine methylation and serine phosphorylation.
In: Frontiers in Cell and Developmental Biology, 2022, 10
doi: 10.26083/tuprints-00022455
Article, Secondary publication, Publisher's Version

[img] Text
fcell-10-941493.pdf
Copyright Information: CC BY 4.0 International - Creative Commons, Attribution.

Download (4MB)
[img] Text
DataSheet1.pdf
Copyright Information: CC BY 4.0 International - Creative Commons, Attribution.

Download (13MB)
Item Type: Article
Type of entry: Secondary publication
Title: MeCP2 heterochromatin organization is modulated by arginine methylation and serine phosphorylation
Language: English
Date: 24 October 2022
Place of Publication: Darmstadt
Year of primary publication: 2022
Publisher: Frontiers Media S.A.
Journal or Publication Title: Frontiers in Cell and Developmental Biology
Volume of the journal: 10
Collation: 22 Seiten
DOI: 10.26083/tuprints-00022455
Corresponding Links:
Origin: Secondary publication DeepGreen
Abstract:

Rett syndrome is a human intellectual disability disorder that is associated with mutations in the X-linked MECP2 gene. The epigenetic reader MeCP2 binds to methylated cytosines on the DNA and regulates chromatin organization. We have shown previously that MECP2 Rett syndrome missense mutations are impaired in chromatin binding and heterochromatin reorganization. Here, we performed a proteomics analysis of post-translational modifications of MeCP2 isolated from adult mouse brain. We show that MeCP2 carries various post-translational modifications, among them phosphorylation on S80 and S421, which lead to minor changes in either heterochromatin binding kinetics or clustering. We found that MeCP2 is (di)methylated on several arginines and that this modification alters heterochromatin organization. Interestingly, we identified the Rett syndrome mutation site R106 as a dimethylation site. In addition, co-expression of protein arginine methyltransferases (PRMT)1 and PRMT6 lead to a decrease of heterochromatin clustering. Altogether, we identified and validated novel modifications of MeCP2 in the brain and show that these can modulate its ability to bind as well as reorganize heterochromatin, which may play a role in the pathology of Rett syndrome.

Uncontrolled Keywords: arginine (di)methylation, heterochromatin organization, MeCP2, protein arginine methyltransferases, Rett syndrome
Status: Publisher's Version
URN: urn:nbn:de:tuda-tuprints-224556
Classification DDC: 500 Science and mathematics > 570 Life sciences, biology
Divisions: 10 Department of Biology > Cell Biology and Epigenetics
Date Deposited: 24 Oct 2022 13:13
Last Modified: 14 Nov 2023 19:05
SWORD Depositor: Deep Green
URI: https://tuprints.ulb.tu-darmstadt.de/id/eprint/22455
PPN: 500857520
Export:
Actions (login required)
View Item View Item